1. Home
  2. ICD-10-PCS MS-DRG V42.0
  3. Procedure Codes in MS-DRG 266 - Endovascular Cardiac Valve Replacement And Supplement Procedures With MCC

Procedure Codes in MS-DRG 266 - Endovascular Cardiac Valve Replacement And Supplement Procedures With MCC

The Medicare Severity Diagnosis-Related Group (MS-DRG) is a patient classification system used to categorize hospital cases based on clinical similarity and expected resource use. MS-DRGs organize all possible principal diagnoses into mutually exclusive groups known as Major Diagnostic Categories (MDCs), which help determine reimbursement under the Medicare Inpatient Prospective Payment System.

This section lists the procedure codes included in MS-DRG V42.0: Endovascular Cardiac Valve Replacement and Supplement Procedures with MCC from October 1, 2024, through September 30, 2025.

MS-DRG: 266

MS-DRG Title: Endovascular Cardiac Valve Replacement and Supplement Procedures with MCC

MCD: 05

Relative Weight: Relative Weight
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.

Geometric LOS: Geometric Length of Stay
The geometric mean length of stay (GMLOS) is used by Medicare to calculate the reimbursement for patients whose medical treatment takes a much longer or shorter time than average.

Arithmetic LOS: Arithmetic Length of Stay
The average length of stay (ALOS) reflects the average number of days a patient spends in a hospital for each admission.

  • 02R - Heart and Great Vessels, Replacement

    • 02RF37H - Replacement of Aortic Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach

    • 02RF37Z - Replacement of Aortic Valve with Autologous Tissue Substitute, Percutaneous Approach

    • 02RF38H - Replacement of Aortic Valve with Zooplastic Tissue, Transapical, Percutaneous Approach

    • 02RF38N - Replacement of Aortic Valve with Zooplastic Tissue, using Rapid Deployment Technique, Percutaneous Approach

    • 02RF38Z - Replacement of Aortic Valve with Zooplastic Tissue, Percutaneous Approach

    • 02RF3JH - Replacement of Aortic Valve with Synthetic Substitute, Transapical, Percutaneous Approach

    • 02RF3JZ - Replacement of Aortic Valve with Synthetic Substitute, Percutaneous Approach

    • 02RF3KH - Replacement of Aortic Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach

    • 02RF3KZ - Replacement of Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    • 02RG37H - Replacement of Mitral Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach

    • 02RG37Z - Replacement of Mitral Valve with Autologous Tissue Substitute, Percutaneous Approach

    • 02RG38H - Replacement of Mitral Valve with Zooplastic Tissue, Transapical, Percutaneous Approach

    • 02RG38Z - Replacement of Mitral Valve with Zooplastic Tissue, Percutaneous Approach

    • 02RG3JH - Replacement of Mitral Valve with Synthetic Substitute, Transapical, Percutaneous Approach

    • 02RG3JZ - Replacement of Mitral Valve with Synthetic Substitute, Percutaneous Approach

    • 02RG3KH - Replacement of Mitral Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach

    • 02RG3KZ - Replacement of Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    • 02RH37H - Replacement of Pulmonary Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach

    • 02RH37Z - Replacement of Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Approach

    • 02RH38H - Replacement of Pulmonary Valve with Zooplastic Tissue, Transapical, Percutaneous Approach

    • 02RH38L - Replacement of Pulmonary Valve with Zooplastic Tissue, In Existing Conduit, Percutaneous Approach

    • 02RH38M - Replacement of Pulmonary Valve with Zooplastic Tissue, Native Site, Percutaneous Approach

    • 02RH38Z - Replacement of Pulmonary Valve with Zooplastic Tissue, Percutaneous Approach

    • 02RH3JH - Replacement of Pulmonary Valve with Synthetic Substitute, Transapical, Percutaneous Approach

    • 02RH3JZ - Replacement of Pulmonary Valve with Synthetic Substitute, Percutaneous Approach

    • 02RH3KH - Replacement of Pulmonary Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach

    • 02RH3KZ - Replacement of Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    • 02RJ37H - Replacement of Tricuspid Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach

    • 02RJ37Z - Replacement of Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Approach

    • 02RJ38H - Replacement of Tricuspid Valve with Zooplastic Tissue, Transapical, Percutaneous Approach

    • 02RJ38Z - Replacement of Tricuspid Valve with Zooplastic Tissue, Percutaneous Approach

    • 02RJ3JH - Replacement of Tricuspid Valve with Synthetic Substitute, Transapical, Percutaneous Approach

    • 02RJ3JZ - Replacement of Tricuspid Valve with Synthetic Substitute, Percutaneous Approach

    • 02RJ3KH - Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach

    • 02RJ3KZ - Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Approach

  • 02U - Heart and Great Vessels, Supplement

    • 02UF37J - Supplement Aortic Valve created from Truncal Valve with Autologous Tissue Substitute, Percutaneous Approach

    • 02UF37Z - Supplement Aortic Valve with Autologous Tissue Substitute, Percutaneous Approach

    • 02UF38J - Supplement Aortic Valve created from Truncal Valve with Zooplastic Tissue, Percutaneous Approach

    • 02UF38Z - Supplement Aortic Valve with Zooplastic Tissue, Percutaneous Approach

    • 02UF3JJ - Supplement Aortic Valve created from Truncal Valve with Synthetic Substitute, Percutaneous Approach

    • 02UF3JZ - Supplement Aortic Valve with Synthetic Substitute, Percutaneous Approach

    • 02UF3KJ - Supplement Aortic Valve created from Truncal Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    • 02UF3KZ - Supplement Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    • 02UG37E - Supplement Mitral Valve created from Left Atrioventricular Valve with Autologous Tissue Substitute, Percutaneous Approach

    • 02UG37Z - Supplement Mitral Valve with Autologous Tissue Substitute, Percutaneous Approach

    • 02UG38E - Supplement Mitral Valve created from Left Atrioventricular Valve with Zooplastic Tissue, Percutaneous Approach

    • 02UG38Z - Supplement Mitral Valve with Zooplastic Tissue, Percutaneous Approach

    • 02UG3JE - Supplement Mitral Valve created from Left Atrioventricular Valve with Synthetic Substitute, Percutaneous Approach

    • 02UG3JH - Supplement Mitral Valve with Synthetic Substitute, Transapical, Percutaneous Approach

    • 02UG3JZ - Supplement Mitral Valve with Synthetic Substitute, Percutaneous Approach

    • 02UG3KE - Supplement Mitral Valve created from Left Atrioventricular Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    • 02UG3KZ - Supplement Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    • 02UH37Z - Supplement Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Approach

    • 02UH38Z - Supplement Pulmonary Valve with Zooplastic Tissue, Percutaneous Approach

    • 02UH3JZ - Supplement Pulmonary Valve with Synthetic Substitute, Percutaneous Approach

    • 02UH3KZ - Supplement Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    • 02UJ37G - Supplement Tricuspid Valve created from Right Atrioventricular Valve with Autologous Tissue Substitute, Percutaneous Approach

    • 02UJ37Z - Supplement Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Approach

    • 02UJ38G - Supplement Tricuspid Valve created from Right Atrioventricular Valve with Zooplastic Tissue, Percutaneous Approach

    • 02UJ38Z - Supplement Tricuspid Valve with Zooplastic Tissue, Percutaneous Approach

    • 02UJ3JG - Supplement Tricuspid Valve created from Right Atrioventricular Valve with Synthetic Substitute, Percutaneous Approach

    • 02UJ3JZ - Supplement Tricuspid Valve with Synthetic Substitute, Percutaneous Approach

    • 02UJ3KG - Supplement Tricuspid Valve created from Right Atrioventricular Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    • 02UJ3KZ - Supplement Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Approach

  • X2R - New Technology, Cardiovascular System, Replacement

    • X2RJ3RA - Replacement of Tricuspid Valve with Multi-plane Flex Technology Bioprosthetic Valve, Percutaneous Approach, New Technology Group 10